Sudha Saligram Narayana Rao

Sudha Saligram Narayana Rao

Active Director Whole-Time Director DIN 01726325
DIN 01726325 First appointment Sep 1999 Primary industry Life Sciences
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Sep 1999
Shareholding value •••• Premium profile

About Sudha Saligram Narayana Rao

Data last updated:

Sudha Saligram Narayana Rao is a Whole-Time Director at Genotypic Technology Private Limited (since 1999), Director at Dhiti Omics Technologies Private Limited (since 2014) and Director at Genstride Technologies Private Limited (since 2026). The companies operate in Life Sciences and Infrastructure and Utilities. The 2 current companies with reported revenue have a combined latest revenue of ₹46.29 Cr; the largest is Genotypic Technology Private Limited at ₹39.04 Cr (FY 2025). Earlier, Sudha Saligram Narayana Rao was a Nominee Director at Bangalore Bioinnovation Centre (2022–2025).

DIN 01726325
Primary Designation Whole-Time Director
Industry Life Sciences
First Appointment 29 Sep 1999
Oldest Company Age 28 yrs
Largest company Genotypic Technology Private Limited · ₹39.04 Cr (FY 2025)
Combined revenue ₹46.29 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Genotypic Technology Private Limited U72200KA1998PTC049038
Whole-Time Director29 Sep 19991998₹39.04 Cr (FY 2025)Active
Director24 Jun 20142014₹7.24 Cr (FY 2025)Active
Director28 Jul 20262026Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bangalore Bioinnovation Centre U85310KA2015NPL079765
Nominee Director29 Jun 20222015₹13.85 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Dhiti Omics Technologies Private Limited
Genotypic Technology Private Limited
Genstride Technologies Private Limited
Bangalore Bioinnovation Centre
Premium access

Shareholding and investment profile for Sudha Saligram Narayana Rao

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sudha Saligram Narayana Rao

Sudha Saligram Narayana Rao currently holds 3 directorships: Genotypic Technology Private Limited (Whole-Time Director, since 29 Sep 1999, revenue ₹39.04 Cr (FY 2025)); Dhiti Omics Technologies Private Limited (Director, since 24 Jun 2014, revenue ₹7.24 Cr (FY 2025)); Genstride Technologies Private Limited (Director, since 28 Jul 2026).

Sudha Saligram Narayana Rao was first appointed on 29 Sep 1999 as Whole-Time Director at Genotypic Technology Private Limited. The most recent appointment on record is 28 Jul 2026 at Genstride Technologies Private Limited.

The 2 current companies of Sudha Saligram Narayana Rao that report revenue have a combined latest revenue of ₹46.29 Cr: Genotypic Technology Private Limited ₹39.04 Cr (FY 2025); Dhiti Omics Technologies Private Limited ₹7.24 Cr (FY 2025).

Sudha Saligram Narayana Rao held 1 earlier board appointment: Bangalore Bioinnovation Centre (Nominee Director, 29 Jun 2022 to 01 Jul 2025).

The current boards of Sudha Saligram Narayana Rao's companies include Raja Chinnadurai Mugasimangalam (Genotypic Technology Private Limited), Ramesh Kannan (Dhiti Omics Technologies Private Limited), Mohamed Aiyaz (Genstride Technologies Private Limited), Sanjeev Irappa Kamte (Genstride Technologies Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available